Condition
Embryonal Tumor With Multilayered Rosettes clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Embryonal Tumor With Multilayered Rosettes clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Canada (1)). By phase: Phase 1 (2), Phase 1/2 (1), Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Embryonal Tumor With Multilayered Rosettes clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| B7-H3 CAR T cells for recurrent brain tumors in kids and young adults | Phase 1 | Boston, Massachusetts and 1 other locations | Recruiting | Feb 5, 2026 |
| Intrathecal topotecan with maintenance chemotherapy after consolidation for high‑risk embryonal brain tumors in children under 6 | Early Phase 1 | Calgary, Alberta and 12 other locations | Recruiting | Apr 24, 2025 |
| Treatment for children with Embryonal Tumor With Multilayered Rosettes | Phase 2 | Birmingham, Alabama and 7 other locations | Recruiting | Mar 6, 2025 |
| Eflornithine (DFMO) plus AMXT 1501 for neuroblastoma, CNS tumors, and sarcomas | Phase 1/2 | Birmingham, Alabama and 13 other locations | Recruiting | Jun 18, 2024 |
| Immunotherapy using personalized T cells for pediatric brain tumors | Phase 1 | Washington D.C., District of Columbia | Recruiting | Jan 5, 2024 |
| Registry for children with a rare brain tumor called ETMR | — | Hackensack, New Jersey | Recruiting | Mar 12, 2021 |
All recruiting trials (6)
-
B7-H3 CAR T cells for recurrent brain tumors in kids and young adults
This early-phase trial tests a personalized CAR T-cell therapy called B7-H3 CAR T for children and young adults with recurrent or progressive brain tumors.
-
Intrathecal topotecan with maintenance chemotherapy after consolidation for high‑risk embryonal brain tumors in children under 6
This study will test whether monthly intrathecal topotecan plus a year of oral maintenance chemotherapy after high‑dose consolidation is feasible and tolerable for children under 6 with high‑risk embryonal brain tumors.
-
Treatment for children with Embryonal Tumor With Multilayered Rosettes
This study is testing a combination of chemotherapy and radiation to see if it helps children with a specific type of brain tumor called ETMR live longer and stay healthy after treatment.
-
Eflornithine (DFMO) plus AMXT 1501 for neuroblastoma, CNS tumors, and sarcomas
This trial tests whether adding the oral drug AMXT 1501 to oral DFMO can help children and young adults (diagnosed by age 21) with relapsed or refractory neuroblastoma, ETMR, ATRT, Ewing sarcoma, osteosarcoma, or newly diagnosed DIPG.
-
Immunotherapy using personalized T cells for pediatric brain tumors
This study is testing a new treatment using personalized immune cells to help young children with certain brain tumors that haven't completely gone away after standard treatment.
-
Registry for children with a rare brain tumor called ETMR
This study is creating a detailed registry to collect important health information about children with a rare brain tumor called ETMR to improve treatment and understand their outcomes better.
Related topics
Quick answers
How many Embryonal Tumor With Multilayered Rosettes clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.